Shenzhen Weiguang Biological Products Co., Ltd. (SHE:002880)
China · Delayed Price · Currency is CNY 30.85
-0.01 (-0.03%)
Feb 13, 2026, 3:04 PM CST
SHE:002880 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 228.68 | 253.52 | 218.65 | 117.52 | 205.44 | 190.4 |
Depreciation & Amortization | 116.77 | 116.77 | 87.31 | 65.26 | 55.48 | 45.72 |
Other Amortization | 3.67 | 3.67 | 2.13 | 1.59 | 1.29 | 0.75 |
Loss (Gain) From Sale of Assets | -0.05 | -0.05 | - | -0.04 | - | -0.07 |
Asset Writedown & Restructuring Costs | -0.1 | -0.1 | 0.1 | 0.43 | 0.32 | 0.58 |
Loss (Gain) From Sale of Investments | 8.53 | 8.53 | -7.8 | -18.68 | -0.74 | - |
Provision & Write-off of Bad Debts | 4.08 | 4.08 | -2.5 | -1.34 | 1.11 | -1.38 |
Other Operating Activities | 39.44 | 24.46 | 12.95 | 6.52 | 3.1 | 0.24 |
Change in Accounts Receivable | -144.48 | -144.48 | 88.21 | 33.52 | -2.72 | -15.57 |
Change in Inventory | -119.9 | -119.9 | -50.56 | -183.83 | -37.76 | 83.8 |
Change in Accounts Payable | 35.01 | 35.01 | 35.62 | -20.06 | 20.25 | -0.92 |
Change in Other Net Operating Assets | -3.51 | -3.51 | 20.86 | - | - | - |
Operating Cash Flow | 167.91 | 177.77 | 397.94 | 1.2 | 246.89 | 303.96 |
Operating Cash Flow Growth | -40.68% | -55.33% | 33088.09% | -99.51% | -18.78% | 63.68% |
Capital Expenditures | -196.65 | -255.5 | -328.85 | -327.37 | -240.83 | -189.19 |
Sale of Property, Plant & Equipment | 0.04 | 0.17 | 0.07 | 0.12 | 0.23 | 0.61 |
Cash Acquisitions | - | - | -22.39 | - | - | - |
Investment in Securities | 19 | 15 | -1 | -160 | -49.48 | -14 |
Other Investing Activities | -83.04 | 2.13 | - | -0 | - | - |
Investing Cash Flow | -260.65 | -238.2 | -352.17 | -487.26 | -290.08 | -202.59 |
Short-Term Debt Issued | - | - | - | - | - | 260 |
Long-Term Debt Issued | - | 252.76 | 179.97 | 528.48 | 75 | - |
Total Debt Issued | 140.81 | 252.76 | 179.97 | 528.48 | 75 | 260 |
Short-Term Debt Repaid | - | - | - | - | - | -178 |
Long-Term Debt Repaid | - | -103.16 | -202.55 | -26.39 | -133.35 | - |
Total Debt Repaid | -166.67 | -103.16 | -202.55 | -26.39 | -133.35 | -178 |
Net Debt Issued (Repaid) | -25.87 | 149.6 | -22.58 | 502.09 | -58.35 | 82 |
Issuance of Common Stock | - | - | - | - | 4 | - |
Common Dividends Paid | -67.41 | -65.88 | -65.6 | -57.68 | -41.82 | -35.68 |
Other Financing Activities | 9.78 | - | - | 3.5 | - | 19.21 |
Financing Cash Flow | -83.49 | 83.72 | -88.18 | 447.9 | -96.18 | 65.53 |
Net Cash Flow | -176.24 | 23.29 | -42.41 | -38.16 | -139.37 | 166.9 |
Free Cash Flow | -28.74 | -77.73 | 69.08 | -326.17 | 6.06 | 114.76 |
Free Cash Flow Growth | - | - | - | - | -94.72% | 6.35% |
Free Cash Flow Margin | -2.52% | -6.46% | 6.59% | -48.83% | 0.67% | 12.69% |
Free Cash Flow Per Share | -0.13 | -0.34 | 0.30 | -1.44 | 0.03 | 0.51 |
Cash Interest Paid | - | - | - | 1.11 | - | - |
Cash Income Tax Paid | 107.11 | 85.12 | 72.15 | 16.25 | 71.17 | 72.12 |
Levered Free Cash Flow | -106.66 | -150.43 | 12.4 | -372.74 | -22.58 | 37.3 |
Unlevered Free Cash Flow | -93.23 | -136.72 | 21.36 | -371.45 | -21.41 | 37.96 |
Change in Working Capital | -233.12 | -233.12 | 87.09 | -170.05 | -19.12 | 67.72 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.